INTANGIBLE ASSETS AND GOODWILL (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Intangible Asset, Goodwill and Other [Abstract] |
|
| Schedule of finite-lived intangible assets |
The major components of intangible assets consist of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | | (in millions) | | Gross Carrying Amount | | Accumulated Amortization and Impairments | | Net Carrying Amount | | Gross Carrying Amount | | Accumulated Amortization and Impairments | | Net Carrying Amount | | Finite-lived intangible assets: | | | | | | | | | | | | | | Product brands | | $ | 22,487 | | | $ | (20,338) | | | $ | 2,149 | | | $ | 22,534 | | | $ | (19,981) | | | $ | 2,553 | | | Corporate brands | | 1,002 | | | (828) | | | 174 | | | 1,003 | | | (789) | | | 214 | | | Product rights/patents | | 3,264 | | | (3,248) | | | 16 | | | 3,271 | | | (3,253) | | | 18 | | | Partner relationships, technology and other | | 437 | | | (395) | | | 42 | | | 445 | | | (385) | | | 60 | | | Total finite-lived intangible assets | | 27,190 | | | (24,809) | | | 2,381 | | | 27,253 | | | (24,408) | | | 2,845 | | | Acquired IPR&D | | 100 | | | — | | | 100 | | | 100 | | | — | | | 100 | | | B&L Trademark | | 1,698 | | | — | | | 1,698 | | | 1,698 | | | — | | | 1,698 | | | | $ | 28,988 | | | $ | (24,809) | | | $ | 4,179 | | | $ | 29,051 | | | $ | (24,408) | | | $ | 4,643 | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Schedule of indefinite-lived intangible assets |
The major components of intangible assets consist of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | June 30, 2026 | | December 31, 2025 | | (in millions) | | Gross Carrying Amount | | Accumulated Amortization and Impairments | | Net Carrying Amount | | Gross Carrying Amount | | Accumulated Amortization and Impairments | | Net Carrying Amount | | Finite-lived intangible assets: | | | | | | | | | | | | | | Product brands | | $ | 22,487 | | | $ | (20,338) | | | $ | 2,149 | | | $ | 22,534 | | | $ | (19,981) | | | $ | 2,553 | | | Corporate brands | | 1,002 | | | (828) | | | 174 | | | 1,003 | | | (789) | | | 214 | | | Product rights/patents | | 3,264 | | | (3,248) | | | 16 | | | 3,271 | | | (3,253) | | | 18 | | | Partner relationships, technology and other | | 437 | | | (395) | | | 42 | | | 445 | | | (385) | | | 60 | | | Total finite-lived intangible assets | | 27,190 | | | (24,809) | | | 2,381 | | | 27,253 | | | (24,408) | | | 2,845 | | | Acquired IPR&D | | 100 | | | — | | | 100 | | | 100 | | | — | | | 100 | | | B&L Trademark | | 1,698 | | | — | | | 1,698 | | | 1,698 | | | — | | | 1,698 | | | | $ | 28,988 | | | $ | (24,809) | | | $ | 4,179 | | | $ | 29,051 | | | $ | (24,408) | | | $ | 4,643 | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
| Schedule of estimated aggregate amortization expense for each of the five succeeding years |
Estimated amortization expense of finite-lived intangible assets for the remainder of 2026 and each of the five succeeding years ending December 31 and thereafter is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Remainder of 2026 | | 2027 | | 2028 | | 2029 | | 2030 | | 2031 | | Thereafter | | Total | | | Amortization | | $ | 450 | | | $ | 849 | | | $ | 246 | | | $ | 228 | | | $ | 223 | | | $ | 213 | | | $ | 172 | | | $ | 2,381 | | |
|
| Schedule of changes in the carrying amount of goodwill |
The changes in the carrying amounts of goodwill during the six months ended June 30, 2026 and the year ended December 31, 2025 were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (in millions) | | Salix | | International | | | | Solta Medical | | Diversified | | Bausch + Lomb | | Total | | Balance, January 1, 2025 | | $ | 3,159 | | | $ | 792 | | | | | $ | 115 | | | $ | 1,759 | | | $ | 5,262 | | | $ | 11,087 | | | Additions | | — | | | — | | | | | 22 | | | — | | | 97 | | | 119 | | | Impairment | | — | | | — | | | | | — | | | (145) | | | — | | | (145) | | | Goodwill reclassified to assets held for sale | | — | | | (4) | | | | | — | | | — | | | — | | | (4) | | | Foreign exchange and other | | — | | | 109 | | | | | — | | | (33) | | | 138 | | | 214 | | | Balance, December 31, 2025 | | 3,159 | | | 897 | | | | | 137 | | | 1,581 | | | 5,497 | | | 11,271 | | | Additions | | — | | | — | | | | | 1 | | | — | | | 4 | | | 5 | | | Impairment | | (1,426) | | | — | | | | | — | | | — | | | — | | | (1,426) | | | Foreign exchange and other | | — | | | (19) | | | | | 1 | | | — | | | (39) | | | (57) | | | Balance, June 30, 2026 | | $ | 1,733 | | | $ | 878 | | | | | $ | 139 | | | $ | 1,581 | | | $ | 5,462 | | | $ | 9,793 | |
|